Cross talk between stimulated NF-κB and the tumor suppressor p53

Nuclear factor-κB (NF-κB) and p53 critically determine cancer development and progression. Defining the cross talk between these transcription factors can expand our knowledge on molecular mechanisms of tumorigenesis. Here, we show that induction of replicational stress activates NF-κB p65 and trigg...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oncogene 2010-05, Vol.29 (19), p.2795-2806
Hauptverfasser: Schneider, G, Henrich, A, Greiner, G, Wolf, V, Lovas, A, Wieczorek, M, Wagner, T, Reichardt, S, von Werder, A, Schmid, R M, Weih, F, Heinzel, T, Saur, D, Krämer, O H
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2806
container_issue 19
container_start_page 2795
container_title Oncogene
container_volume 29
creator Schneider, G
Henrich, A
Greiner, G
Wolf, V
Lovas, A
Wieczorek, M
Wagner, T
Reichardt, S
von Werder, A
Schmid, R M
Weih, F
Heinzel, T
Saur, D
Krämer, O H
description Nuclear factor-κB (NF-κB) and p53 critically determine cancer development and progression. Defining the cross talk between these transcription factors can expand our knowledge on molecular mechanisms of tumorigenesis. Here, we show that induction of replicational stress activates NF-κB p65 and triggers its interaction with p53 in the nucleus. Experiments with knockout cells show that p65 and p53 are both required for enhanced NF-κB activity during S-phase checkpoint activation involving ataxia-telangiectasia mutated and checkpoint kinase-1. Accordingly, the pro-inflammatory cytokine tumor necrosis factor-α (TNF-α) also triggers formation of a transcriptionally active complex containing nuclear p65 and p53 on κB response elements. Gene expression analyses revealed that, independent of NF-κB activation in the cytosol, TNF-induced NF-κB-directed gene expression relies on p53. Hence, p53 is unexpectedly necessary for NF-κB-mediated gene expression induced by atypical and classical stimuli. Remarkably, data from gain- and loss-of function approaches argue that anti-apoptotic NF-κB p65 activity is constitutively evoked by a p53 hot-spot mutant frequently found in tumors. Our observations suggest explanations for the outstanding question why p53 mutations rather than p53 deletions arise in tumors of various origins.
doi_str_mv 10.1038/onc.2010.46
format Article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_journals_2641403982</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A227198367</galeid><sourcerecordid>A227198367</sourcerecordid><originalsourceid>FETCH-LOGICAL-c432t-a029f5d000628c07984d9436e641009c5f2b8e21526988ab6b4a501e325b81e3</originalsourceid><addsrcrecordid>eNptkM1OAyEUhYnRxFpd-QIkxpVOZfgbWNbGqkmjm-4JwzB16vwJTIyv5kP4TNK0sTFpWFwufOdcOABcpmiSIiLuutZMMIod5UdglNKMJ4xJegxGSDKUSEzwKTjzfo0QyiTCIzCduc57GHT9DnMbPq1toQ9VM9Q62AK-zJOf73uo2wKGNwvD0HQO-qHvnfU-bntGzsFJqWtvL3Z1DJbzh-XsKVm8Pj7PpovEUIJDohGWJSviYI6FidMFLSQl3HKaIiQNK3EuLE4Z5lIInfOcaoZSSzDLRSxjcLW17V33MVgf1LobXBsnKhwtKCJS4D210rVVVVt2wWnTVN6oKcZZKgXhWaQmB6i4CttUpmttWcXzf4KbrcBs0nK2VL2rGu2-VIrUJnkVk1eb5BXlkb7ePVV7o-vS6dZU_k8SbQXOCIrc7Zbz8apdWbf_0iHbX9hKjlQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2641403982</pqid></control><display><type>article</type><title>Cross talk between stimulated NF-κB and the tumor suppressor p53</title><source>Springer Nature - Complete Springer Journals</source><source>Nature</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Schneider, G ; Henrich, A ; Greiner, G ; Wolf, V ; Lovas, A ; Wieczorek, M ; Wagner, T ; Reichardt, S ; von Werder, A ; Schmid, R M ; Weih, F ; Heinzel, T ; Saur, D ; Krämer, O H</creator><creatorcontrib>Schneider, G ; Henrich, A ; Greiner, G ; Wolf, V ; Lovas, A ; Wieczorek, M ; Wagner, T ; Reichardt, S ; von Werder, A ; Schmid, R M ; Weih, F ; Heinzel, T ; Saur, D ; Krämer, O H</creatorcontrib><description>Nuclear factor-κB (NF-κB) and p53 critically determine cancer development and progression. Defining the cross talk between these transcription factors can expand our knowledge on molecular mechanisms of tumorigenesis. Here, we show that induction of replicational stress activates NF-κB p65 and triggers its interaction with p53 in the nucleus. Experiments with knockout cells show that p65 and p53 are both required for enhanced NF-κB activity during S-phase checkpoint activation involving ataxia-telangiectasia mutated and checkpoint kinase-1. Accordingly, the pro-inflammatory cytokine tumor necrosis factor-α (TNF-α) also triggers formation of a transcriptionally active complex containing nuclear p65 and p53 on κB response elements. Gene expression analyses revealed that, independent of NF-κB activation in the cytosol, TNF-induced NF-κB-directed gene expression relies on p53. Hence, p53 is unexpectedly necessary for NF-κB-mediated gene expression induced by atypical and classical stimuli. Remarkably, data from gain- and loss-of function approaches argue that anti-apoptotic NF-κB p65 activity is constitutively evoked by a p53 hot-spot mutant frequently found in tumors. Our observations suggest explanations for the outstanding question why p53 mutations rather than p53 deletions arise in tumors of various origins.</description><identifier>ISSN: 0950-9232</identifier><identifier>EISSN: 1476-5594</identifier><identifier>DOI: 10.1038/onc.2010.46</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>631/250/516/1909 ; 631/67/581 ; 631/80/86 ; 692/699/67 ; Ageing, cell death ; Apoptosis ; Ataxia ; Biological and medical sciences ; Cell Biology ; Cell physiology ; Cell transformation and carcinogenesis. Action of oncogenes and antioncogenes ; Cytosol ; Fundamental and applied biological sciences. Psychology ; Gene expression ; Genetic aspects ; Health aspects ; Human Genetics ; Inflammation ; Internal Medicine ; Kinases ; Medicine ; Medicine &amp; Public Health ; Molecular and cellular biology ; Molecular modelling ; NF-κB protein ; Oncology ; original-article ; p53 Protein ; Physiological aspects ; Regulatory sequences ; Risk factors ; Transcription factors ; Tumor necrosis factor ; Tumor necrosis factor-TNF ; Tumor necrosis factor-α ; Tumor suppressor genes ; Tumorigenesis ; Tumors</subject><ispartof>Oncogene, 2010-05, Vol.29 (19), p.2795-2806</ispartof><rights>Macmillan Publishers Limited 2010</rights><rights>2015 INIST-CNRS</rights><rights>COPYRIGHT 2010 Nature Publishing Group</rights><rights>Macmillan Publishers Limited 2010.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c432t-a029f5d000628c07984d9436e641009c5f2b8e21526988ab6b4a501e325b81e3</citedby><cites>FETCH-LOGICAL-c432t-a029f5d000628c07984d9436e641009c5f2b8e21526988ab6b4a501e325b81e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1038/onc.2010.46$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1038/onc.2010.46$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=22782730$$DView record in Pascal Francis$$Hfree_for_read</backlink></links><search><creatorcontrib>Schneider, G</creatorcontrib><creatorcontrib>Henrich, A</creatorcontrib><creatorcontrib>Greiner, G</creatorcontrib><creatorcontrib>Wolf, V</creatorcontrib><creatorcontrib>Lovas, A</creatorcontrib><creatorcontrib>Wieczorek, M</creatorcontrib><creatorcontrib>Wagner, T</creatorcontrib><creatorcontrib>Reichardt, S</creatorcontrib><creatorcontrib>von Werder, A</creatorcontrib><creatorcontrib>Schmid, R M</creatorcontrib><creatorcontrib>Weih, F</creatorcontrib><creatorcontrib>Heinzel, T</creatorcontrib><creatorcontrib>Saur, D</creatorcontrib><creatorcontrib>Krämer, O H</creatorcontrib><title>Cross talk between stimulated NF-κB and the tumor suppressor p53</title><title>Oncogene</title><addtitle>Oncogene</addtitle><description>Nuclear factor-κB (NF-κB) and p53 critically determine cancer development and progression. Defining the cross talk between these transcription factors can expand our knowledge on molecular mechanisms of tumorigenesis. Here, we show that induction of replicational stress activates NF-κB p65 and triggers its interaction with p53 in the nucleus. Experiments with knockout cells show that p65 and p53 are both required for enhanced NF-κB activity during S-phase checkpoint activation involving ataxia-telangiectasia mutated and checkpoint kinase-1. Accordingly, the pro-inflammatory cytokine tumor necrosis factor-α (TNF-α) also triggers formation of a transcriptionally active complex containing nuclear p65 and p53 on κB response elements. Gene expression analyses revealed that, independent of NF-κB activation in the cytosol, TNF-induced NF-κB-directed gene expression relies on p53. Hence, p53 is unexpectedly necessary for NF-κB-mediated gene expression induced by atypical and classical stimuli. Remarkably, data from gain- and loss-of function approaches argue that anti-apoptotic NF-κB p65 activity is constitutively evoked by a p53 hot-spot mutant frequently found in tumors. Our observations suggest explanations for the outstanding question why p53 mutations rather than p53 deletions arise in tumors of various origins.</description><subject>631/250/516/1909</subject><subject>631/67/581</subject><subject>631/80/86</subject><subject>692/699/67</subject><subject>Ageing, cell death</subject><subject>Apoptosis</subject><subject>Ataxia</subject><subject>Biological and medical sciences</subject><subject>Cell Biology</subject><subject>Cell physiology</subject><subject>Cell transformation and carcinogenesis. Action of oncogenes and antioncogenes</subject><subject>Cytosol</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Gene expression</subject><subject>Genetic aspects</subject><subject>Health aspects</subject><subject>Human Genetics</subject><subject>Inflammation</subject><subject>Internal Medicine</subject><subject>Kinases</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Molecular and cellular biology</subject><subject>Molecular modelling</subject><subject>NF-κB protein</subject><subject>Oncology</subject><subject>original-article</subject><subject>p53 Protein</subject><subject>Physiological aspects</subject><subject>Regulatory sequences</subject><subject>Risk factors</subject><subject>Transcription factors</subject><subject>Tumor necrosis factor</subject><subject>Tumor necrosis factor-TNF</subject><subject>Tumor necrosis factor-α</subject><subject>Tumor suppressor genes</subject><subject>Tumorigenesis</subject><subject>Tumors</subject><issn>0950-9232</issn><issn>1476-5594</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNptkM1OAyEUhYnRxFpd-QIkxpVOZfgbWNbGqkmjm-4JwzB16vwJTIyv5kP4TNK0sTFpWFwufOdcOABcpmiSIiLuutZMMIod5UdglNKMJ4xJegxGSDKUSEzwKTjzfo0QyiTCIzCduc57GHT9DnMbPq1toQ9VM9Q62AK-zJOf73uo2wKGNwvD0HQO-qHvnfU-bntGzsFJqWtvL3Z1DJbzh-XsKVm8Pj7PpovEUIJDohGWJSviYI6FidMFLSQl3HKaIiQNK3EuLE4Z5lIInfOcaoZSSzDLRSxjcLW17V33MVgf1LobXBsnKhwtKCJS4D210rVVVVt2wWnTVN6oKcZZKgXhWaQmB6i4CttUpmttWcXzf4KbrcBs0nK2VL2rGu2-VIrUJnkVk1eb5BXlkb7ePVV7o-vS6dZU_k8SbQXOCIrc7Zbz8apdWbf_0iHbX9hKjlQ</recordid><startdate>20100513</startdate><enddate>20100513</enddate><creator>Schneider, G</creator><creator>Henrich, A</creator><creator>Greiner, G</creator><creator>Wolf, V</creator><creator>Lovas, A</creator><creator>Wieczorek, M</creator><creator>Wagner, T</creator><creator>Reichardt, S</creator><creator>von Werder, A</creator><creator>Schmid, R M</creator><creator>Weih, F</creator><creator>Heinzel, T</creator><creator>Saur, D</creator><creator>Krämer, O H</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>IQODW</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TM</scope><scope>7TO</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M7P</scope><scope>MBDVC</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>RC3</scope></search><sort><creationdate>20100513</creationdate><title>Cross talk between stimulated NF-κB and the tumor suppressor p53</title><author>Schneider, G ; Henrich, A ; Greiner, G ; Wolf, V ; Lovas, A ; Wieczorek, M ; Wagner, T ; Reichardt, S ; von Werder, A ; Schmid, R M ; Weih, F ; Heinzel, T ; Saur, D ; Krämer, O H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c432t-a029f5d000628c07984d9436e641009c5f2b8e21526988ab6b4a501e325b81e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>631/250/516/1909</topic><topic>631/67/581</topic><topic>631/80/86</topic><topic>692/699/67</topic><topic>Ageing, cell death</topic><topic>Apoptosis</topic><topic>Ataxia</topic><topic>Biological and medical sciences</topic><topic>Cell Biology</topic><topic>Cell physiology</topic><topic>Cell transformation and carcinogenesis. Action of oncogenes and antioncogenes</topic><topic>Cytosol</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Gene expression</topic><topic>Genetic aspects</topic><topic>Health aspects</topic><topic>Human Genetics</topic><topic>Inflammation</topic><topic>Internal Medicine</topic><topic>Kinases</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Molecular and cellular biology</topic><topic>Molecular modelling</topic><topic>NF-κB protein</topic><topic>Oncology</topic><topic>original-article</topic><topic>p53 Protein</topic><topic>Physiological aspects</topic><topic>Regulatory sequences</topic><topic>Risk factors</topic><topic>Transcription factors</topic><topic>Tumor necrosis factor</topic><topic>Tumor necrosis factor-TNF</topic><topic>Tumor necrosis factor-α</topic><topic>Tumor suppressor genes</topic><topic>Tumorigenesis</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Schneider, G</creatorcontrib><creatorcontrib>Henrich, A</creatorcontrib><creatorcontrib>Greiner, G</creatorcontrib><creatorcontrib>Wolf, V</creatorcontrib><creatorcontrib>Lovas, A</creatorcontrib><creatorcontrib>Wieczorek, M</creatorcontrib><creatorcontrib>Wagner, T</creatorcontrib><creatorcontrib>Reichardt, S</creatorcontrib><creatorcontrib>von Werder, A</creatorcontrib><creatorcontrib>Schmid, R M</creatorcontrib><creatorcontrib>Weih, F</creatorcontrib><creatorcontrib>Heinzel, T</creatorcontrib><creatorcontrib>Saur, D</creatorcontrib><creatorcontrib>Krämer, O H</creatorcontrib><collection>Pascal-Francis</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>Genetics Abstracts</collection><jtitle>Oncogene</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Schneider, G</au><au>Henrich, A</au><au>Greiner, G</au><au>Wolf, V</au><au>Lovas, A</au><au>Wieczorek, M</au><au>Wagner, T</au><au>Reichardt, S</au><au>von Werder, A</au><au>Schmid, R M</au><au>Weih, F</au><au>Heinzel, T</au><au>Saur, D</au><au>Krämer, O H</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cross talk between stimulated NF-κB and the tumor suppressor p53</atitle><jtitle>Oncogene</jtitle><stitle>Oncogene</stitle><date>2010-05-13</date><risdate>2010</risdate><volume>29</volume><issue>19</issue><spage>2795</spage><epage>2806</epage><pages>2795-2806</pages><issn>0950-9232</issn><eissn>1476-5594</eissn><abstract>Nuclear factor-κB (NF-κB) and p53 critically determine cancer development and progression. Defining the cross talk between these transcription factors can expand our knowledge on molecular mechanisms of tumorigenesis. Here, we show that induction of replicational stress activates NF-κB p65 and triggers its interaction with p53 in the nucleus. Experiments with knockout cells show that p65 and p53 are both required for enhanced NF-κB activity during S-phase checkpoint activation involving ataxia-telangiectasia mutated and checkpoint kinase-1. Accordingly, the pro-inflammatory cytokine tumor necrosis factor-α (TNF-α) also triggers formation of a transcriptionally active complex containing nuclear p65 and p53 on κB response elements. Gene expression analyses revealed that, independent of NF-κB activation in the cytosol, TNF-induced NF-κB-directed gene expression relies on p53. Hence, p53 is unexpectedly necessary for NF-κB-mediated gene expression induced by atypical and classical stimuli. Remarkably, data from gain- and loss-of function approaches argue that anti-apoptotic NF-κB p65 activity is constitutively evoked by a p53 hot-spot mutant frequently found in tumors. Our observations suggest explanations for the outstanding question why p53 mutations rather than p53 deletions arise in tumors of various origins.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><doi>10.1038/onc.2010.46</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0950-9232
ispartof Oncogene, 2010-05, Vol.29 (19), p.2795-2806
issn 0950-9232
1476-5594
language eng
recordid cdi_proquest_journals_2641403982
source Springer Nature - Complete Springer Journals; Nature; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects 631/250/516/1909
631/67/581
631/80/86
692/699/67
Ageing, cell death
Apoptosis
Ataxia
Biological and medical sciences
Cell Biology
Cell physiology
Cell transformation and carcinogenesis. Action of oncogenes and antioncogenes
Cytosol
Fundamental and applied biological sciences. Psychology
Gene expression
Genetic aspects
Health aspects
Human Genetics
Inflammation
Internal Medicine
Kinases
Medicine
Medicine & Public Health
Molecular and cellular biology
Molecular modelling
NF-κB protein
Oncology
original-article
p53 Protein
Physiological aspects
Regulatory sequences
Risk factors
Transcription factors
Tumor necrosis factor
Tumor necrosis factor-TNF
Tumor necrosis factor-α
Tumor suppressor genes
Tumorigenesis
Tumors
title Cross talk between stimulated NF-κB and the tumor suppressor p53
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T23%3A29%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cross%20talk%20between%20stimulated%20NF-%CE%BAB%20and%20the%20tumor%20suppressor%20p53&rft.jtitle=Oncogene&rft.au=Schneider,%20G&rft.date=2010-05-13&rft.volume=29&rft.issue=19&rft.spage=2795&rft.epage=2806&rft.pages=2795-2806&rft.issn=0950-9232&rft.eissn=1476-5594&rft_id=info:doi/10.1038/onc.2010.46&rft_dat=%3Cgale_proqu%3EA227198367%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2641403982&rft_id=info:pmid/&rft_galeid=A227198367&rfr_iscdi=true